Article info
PostScript
Correspondence
Dosing of intravenous immunoglobulin in COVID-19 vaccine-induced immune thrombocytopenia and thrombosis
- Correspondence to Dr Siraj A Misbah, Immunology, Oxford University Hospitals NHS Foundation Trust, OX3 9DU, Oxford, UK; siraj.misbah{at}ouh.nhs.uk
Citation
Dosing of intravenous immunoglobulin in COVID-19 vaccine-induced immune thrombocytopenia and thrombosis
Publication history
- Received May 11, 2022
- Accepted September 15, 2022
- First published September 29, 2022.
Online issue publication
January 19, 2023
Article Versions
- Previous version (29 September 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.